BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8749467)

  • 1. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma].
    Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 5. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Kubota T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():625-8. PubMed ID: 16149595
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor markers of hepatocellular carcinoma].
    Kubo S; Matsukawa M
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2203-6. PubMed ID: 15628773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
    Nasu M; Soma T; Fukushima H; Kudo K; Matsubara O
    Mod Pathol; 1997 Oct; 10(10):1054-8. PubMed ID: 9346187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application studies on AFP-L3 detected by micro-spin column method].
    Gao J; Xu AF; Zheng HY; Chen G; Wang MC; Lou GQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):461-3. PubMed ID: 21604577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cutaneous metastases of hepatocarcinoma].
    Pérez MM; Puig L; Orobitg J; Conangla M; de Moragas JM
    Rev Clin Esp; 1988 Jun; 183(1):50-1. PubMed ID: 2459734
    [No Abstract]   [Full Text] [Related]  

  • 13. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
    Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers for hepatocellular carcinoma].
    Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
    Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the diagnostic value of alpha-1-fetoprotein (AFP) in hepatocellular carcinoma.
    Zeana C; Macarie C
    Acta Med Pol; 1976; 17(2):159-3. PubMed ID: 59516
    [No Abstract]   [Full Text] [Related]  

  • 18. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
    Torbenson M; Kannangai R; Abraham S; Sahin F; Choti M; Wang J
    Am J Clin Pathol; 2004 Sep; 122(3):377-82. PubMed ID: 15362367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
    Sato K; Tanaka M; Kusaba T; Fukuda H; Tanikawa K
    Oncol Rep; 1998; 5(2):355-8. PubMed ID: 9468556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
    Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
    J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.